At-Home HPV test kits could boost cervical cancer screening in Hard-to-Reach women
NCT ID NCT04716127
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether offering a vaginal self-sampling kit directly to women aged 50-65 who had not had a cervical smear in over three years would increase screening participation. Women received a kit to use at home and mail to a lab for HPV testing. The goal was to see how many accepted the kit and completed the test, with a focus on reaching underserved populations in southern France.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
vaginal self-sampling kit for HPV testing
What this could lead to
If successful, this approach could increase cervical cancer screening rates among women who currently avoid it, helping catch the disease earlier.
What could go wrong
This is a completed behavioral study, not a treatment trial. It tests a screening method, not a cure, and results may not apply to other regions or age groups.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CERVICAL CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Arnaud de Villeneuve Hospital, clinical trials Department
Montpellier, Herault, 34295, France
-
Mammobile Hérault
Montpellier, France